Concepedia

Masamichi Hashiba

MH

Statistics

Publications

9

Citations

299

H-Index

9

Active since

2002

Affiliations

Mochida Pharmaceutical (Japan)(Current)

University of Shizuoka

Shimane University

Osaka City University

Masamichi Hashiba is an author at Mochida Pharmaceutical (Japan) specializing in medicine, pharmacology, and toxicology.

Publications per year

2002–2019

9

Publications

9

Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor

Tetsuya Taniguchi, Naoki Ashizawa, Koji Matsumoto et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 105 citations · Full text

, , +14

Potentials and limitations of nonclinical safety assessment for predicting clinical adverse drug reactions: correlation analysis of 142 approved drugs in Japan

Chihiro Tamaki, Takashi Nagayama, Masamichi Hashiba et al. · The Journal of Toxicological Sciences · 2013 · 79 citations · Full text

, , +17

Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders

Hideo Koh, Mizuki Aimoto, Takako Katayama et al. · Journal of Infection and Chemotherapy · 2016 · 25 citations · Full text

, , +13

Change in the gene expression of hepatic tamoxifen-metabolizing enzymes during the process of tamoxifen-induced hepatocarcinogenesis in female rats

Toshihiko Kasahara, Masamichi Hashiba, Tsuyoshi Harada et al. · Carcinogenesis · 2002 · 24 citations · Full text

, , +17

Dienogest inhibits C-C motif chemokine ligand 20 expression in human endometriotic epithelial cells

Shizuka Mita, Masanori Nakakuki, Masayuki Ichioka et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2017 · 16 citations

, , +14

1–5 of 9